1. INTRODUCTION
The Mouse Hepatitis disease which is approximately depending to SARS and MERS corona virus, has long served as a model of study. This virus infects several of human host's cells and also sometimes animal, that can be also, carry out their infection and replication. In addition, several proteins have a basic role in this replication mechanism. In these cases, there are necessary for understanding the definition of those proteins in view point of related mechanisms [1]. These proteins consist of transcription / replication combinations of RNA, several proteins, and two structures of proteases. Those proteases represent major roles to incision the polyproteins from all of the functional components. The main part proteases of these viruses make most of these cuts [2–4]. The SARS-CoV-2 that is currently posing most risk in “Wuhan” consist of a dimer proteins same as to serine proteases including Trypsin, Cysteine and Methionine amino acids. This dimerization has peptides- analogous inhibitor bound in center of active sites. This couple proteases in the SARS are the basic proteases same as the Wuhan's viruses that consist of several splits at 11 sites in the polyproteins. The codon of RNA in the Covid-19 is a positive layer and related units contains: Spike protein or (S), envelope protein or (E) and membrane structure (M) with nuclei-capsid phosphoprotein (Scheme 1) [5–7]. Transcribed non-structural proteins consist of: NSP1, NSP4, ORF1(ab), ORF3(a), ORF6, ORF7(a), ORF9, ORF8 and ORF10 (Table 1). Although researchers have discovered the structure of covid-19 proteins and also some non-structural components, the covid-19 has strong genetic potential characteristics that a few of them are basically the cause of human death [8]. As instance for the envelope protein ion channel (CoV EIC) can be signified in modulating virion release and Covid19-host interaction [9. Moreover, Spike, ORF3a and ORF8 proteins are completely different from other SARS-like proteins. Recently researchers indicated the mechanism of the covid-19 diffusion into the epithelial cells via the s-protein. This interaction with the ACE2 receptors causes human disease. However structural evaluation of the S-protein from the covid-19 and S-protein is due to the weakly binds of the ACE2 receptors. In addition, due to a lack of important experimental method the mechanism of viral proteins (Table 1) are still unknown [10]. Since the corona virus pandemic evolves, researchers have been competed for studding and understanding more about COVID-19. A few months ago in March, a novel study indicated that the S-protein interacted with the ACE2 receptor from covid-19 and the reaction can be terminated via the enzyme TMPRSS2 (Table 1) [11].
Human genome | Covid-19 genome | Biological system | Drug target | Protein system |
---|---|---|---|---|
POLA1 | Nsp1 | DNA replication | DNA polymerase (α) | |
POLA2 | Nsp1 | DNA replication | DNA polymerase (α) | |
COLGALT1 | Nsp1 | DNA replication | DNA polymerase (α) | |
PKP2 | Nsp1 | DNA replication | DNA polymerase (α) | |
POLA1 | Nsp1 | DNA replication | DNA polymerase (α) | |
POLA2 | Nsp1 | DNA replication | DNA polymerase (α) | |
COLGALT1 | Nsp1 | DNA replication | DNA polymerase (α) | |
PKP2 | Nsp1 | DNA replication | DNA polymerase (α) | |
POLA1 | Nsp1 | DNA replication | DNA polymerase (α) | |
POLA2 | Nsp1 | DNA replication | DNA polymerase (α) | |
TIMM10 | Nsp4 | Mitochondria | TIM Complex | |
TIMM10B | Nsp4 | Mitochondria | TIM Complex | |
TIMM9 | Nsp4 | Mitochondria | TIM Complex | |
TIMM29 | Nsp4 | Mitochondria | TIM Complex | |
ACAD9 | Orf9c | Mitochondria | ||
FAR2 | Orf9c | Mitochondria | ||
WFS1 | Orf9c | Mitochondria | ||
PIGO | Orf9c | Mitochondria | ||
RETREG3 | Orf9c | Mitochondria | ||
UBXN8 | Orf9c | Mitochondria | ||
NLRX1 | Orf9c | Mitochondria | ||
TMEM97 | Orf9c | Mitochondria | Potential Drug Candidate | |
ERMP1 | Orf9c | Mitochondria | ||
TAPT1 | Orf9c | Mitochondria | ||
SLC30A6 | Orf9c | Mitochondria | ||
TMED5 | Orf9c | Mitochondria | ||
SCAP | Orf9c | Mitochondria | ||
BCS1L | Orf9c | Mitochondria | ||
NDFIP2 | Orf9c | Mitochondria | ||
DPY19L1 | Orf9c | Mitochondria | ||
F2RL1 | Orf9c | Mitochondria | Potential Drug Candidate | |
GHITM | Orf9c | Mitochondria | ||
ABCC1 | Orf9c | Mitochondria | Potential Drug Candidate | |
TMEM39B | Orf9c | Mitochondria | ||
ALG8 | Orf9c | Mitochondria | ||
FBXL12 | Orf8 | Vesicle trafficking | ||
POGLUT3 | Orf8 | Vesicle trafficking | ||
PLEKHF2 | Orf8 | Vesicle trafficking | ||
CISD3 | Orf8 | Vesicle trafficking | ||
INHBE | Orf8 | Vesicle trafficking | ||
GDF15 | Orf8 | Vesicle trafficking | ||
SMOC1 | Orf8 | Vesicle trafficking | ||
NEU1 | Orf8 | Vesicle trafficking | ||
PLAT | Orf8 | Vesicle trafficking | ||
POGLUT2 | Orf8 | Vesicle trafficking |
1.1 Phosphoprotein
Human proteins that interacted with the proteins of covid-19 in 68 of these proteins can be applied as targets for suitable drugs (Table 1) [12]. SARS-COV-2 strain is about 75% similar to SARS-COV strain and 35% close to the MERSCOV strain [13].
Effects of covid-19 can be occurring within 3 days or sometimes up to two weeks after exposure and there is an equal genomic system known as of β-coronaviruses containing ORF1(ab), NSP1, S- protein from 5'-UTR (untranslated region) and E- protein, M-protein from 3'-UTR and also ORF6(a), ORF7(a), ORF(8), N-protein, ORF(10), and several other non-structural items.
1.2. Neutrophil & Hemoglobin Specification:
By this disease, the neutrophil and hemoglobin amounts have reduced while the indexes of erythrocyte sedimentation rates, serum ferritins, C-reactive proteins, albumins, and lactate dehydrogenases increase significantly. This phenomenon indicates that by decreasing hemoglobin, HEM increases and too much harmful iron will accumulate in the body that will cause smart pain in the human and increase the albumin. Consequently cells produce, large scale of serum ferritin for reducing injury. Hemoglobin contains 4 subunits, 2-alpha and 2-beta, in which each subunit has iron-hemoglobin bonded [14]. Due to Fe2+ the CO2 gases might be separated from hemoglobin and consequently capture O atoms and consequently Fe2+ is oxidized to Fe3+. Hemoglobin can release oxygen atoms and capture CO2 and then Fe3+ is reduced to Fe2+. Because of no clinical trial-based vaccine present, vaccinations are a reliable effective way.
So availability of genomic information and biological algorithms including immunological information might be help researchers for identifying the effective epitopes that can be used for developing vaccines [15,16]. The subunit vaccine consists of several segments of antigen which can be simulated the presence of the natural pathogen towards an immune situation of pathogen [17,18].
Basically, vaccinations designing against MERS, SARS, Ebola, ZIKA and Chikungunya viruses have produced promising results [19,20]. The modeling and simulation methods with genetic algorithms decrease the number of experimental activities and save expenditure and also increase the potential of a successful vaccination. A large amount of peptides involved in the multi-epitopes vaccine in which induce the activation of AIR (Adaptive Immune Response) are suitable and fast method for the viral-infections therapy and covid-19 [21,22]. By this work, SARS-CoV-2 proteomes were explored for determining the antigenic proteins and various B&T-cells epitopes were foreteller with their main histocompatibility complexes characteristic. In addition conserved domain, homologies simulation and molecular docking methods were applied for analyzing the structure of virus-depended proteins. This investigation exhibited that ORF9b and surfaces glycoproteins had a segment for combining with porphyrin to make the complexes structures, while ORF1(ab), ORF10, ORF(3a) coordinately attack the hemoglobin on the 1-β chain for dissociating the iron to form the porphyrin. Moreover the amino acid sequences of target proteins (ORF1, S-(protein), ORF3 (a), E-protein, M-protein, ORF6, ORF(7a), ORF8, ORF10 and ORF9b of SARS- CoV-2 were extracted from the Gen-bank. This phenomenon of the coronavirus inhibited the usual metabolic pathways of hemoglobin, and made human show symptoms of these problems.
2. THEORETICAL DETAILS
2.1. Simulation & Docking analysis
Auto dock software (iGEM-DOCK) has been used and via this tool, the suitable receptors can be distinguished in whole COVID-19 component structures for forming a complex. “iGEMDOCK” is suitable to define the binding site quickly. Molecular docking simulation is a way of finding the best matching pattern among molecules via geometric and energies matching. Following items have been done in docking modeling and simulation : (A), Guess for a place of binding site on the ORF series for separation the iron for forming the porphyrin. (b) Browsing and selecting the protein file and in the initial step, the sequence of polypeptides were extracted from gen-BANK [23]. finally, whole of the sequences can be saved as FASTA format for any further evaluation. (c) Designing the binding sites as a bonded ligand. (d) Designing and preparing the center of the active site via proper ligands. (e) Setting the binding and active sites in view point of size and atoms by the extended radius from the choices ligands - proteins complex. These sequences were extracted from NCBI and also all covid-19 proteins. (f) Hemoglobin -binding proteins, Hemoglobin- oxidase and peptide sequences were used for analyzing conserved chain. It is notable that all polypeptides of Wuhan novel covid-19 were applied for constructing 3-D structures via homology simulation.
IGEMDOCK produces an analysis environment including visualization with analysis tools for applicants that can be utilized the docked situation and related category via the system. The energies poses of each items would be outputted based on the position of “best: Pose”. That information is premeditated with analyzing of these poses. Through looking at the peptide bonded of various ligands, they might be selected through the checked box of ligands. If the cocrystallization ligands are saved on the active site structures, it will be predicted poses. Cluster analyses are the partitioning of the information set into subsets. This information in each subset will share some general aspects. Interaction specifications can be extracted via the protein-ligand intercalation and are accounted atomic kinds in several functional categories. The data in each subset will share some usual properties. Finally, the PDB files were obtained from the bioinformatics sites such as PDB database web sites. By this work, the main items which have been done via molecular docking by “Discovery-Studio” that can be summarized as: Preparation of a ligand perspective, Opening the ligands file, clicking “Prepare Ligands” in the “Dock Ligands” sub-menu of the “Receptor-Ligand Interactions” menu for generating the heme ligands. For the preparing our protein receptors, the protein's pdb file has been generated via homology modeling by the “Dock Ligands” submenu of the “Receptor-Ligand Interactions” menu for generating the protein receptor models for our docking model. We set our docking data via the generating protein receptor system from the “Define and Edit Binding Site” submenus in the “Receptor-Ligand Interactions” menu. The binding energies were calculated via choosing the pose with the largest binding energies.
The Expassy-Protparam tools were applied for determining the chemical & physical properties of molecules [24]. For checking antigenicity of proteins, the related software (Vaxijen 2.0) was also applied [25] and for the predication of secondary polypeptides “Alignment self-optimized prediction method” (SOPMA) tools has been used [26]. In addition several additional online software or tools such as Swiss model [27], “Phyre2”, and “RaptorX” was applied for the tertiary polypeptide segment [27,28]. Model recovered was then refined via “Galaxy Refine Server” and accredited also via Ramachandran plots.
2.2. Genetic and Sequence Analysis
Conserved of viral proteins can be analyzed through MEME website [29–31]. These models are applied for predicting differences between the viral system and human proteins. The 3-D structures of viral proteins were structured through homology modeling of Swiss-model [32,33]. Sequence length extension and homology modeling should be adopted via applying molecular docking, and also the ligand-receptor of viral proteins with porphyrins might be simulated in real situation.
Consequently, a life cycle system of the virus were structured and configured within related proteins of the covid-19 that was proposed. Molecular docking simulation can be built on homology or 3-D molecular modeling. For the analysis of mentioned domains “MEME” suite websites where integrates several keys of predicting is suitable. By the MEME, the polypeptides sequences can be merged into a text file and then select the number of motifs which is needed before any clicking of the "Go" button. For the homology modeling SWISS-MODELs are completely automatic, which can be accessed via a web system through a few running steps such as entering into the Swiss-model, writing the sequence, and clicking "Search Template" for performing a simple template search. Second step is choosing a template for modeling and third is Building Model command that a template model is selected automatically.
2.3. Molecular Dynamic Modeling
Molecular dynamics modeling for polypeptide-ligand complexes were accomplished using the Desmond software [34]. The OPLS and charm force fields were applied for modeling the protein-small molecules interactions. Long-range electrostatic forces were estimated using the Particle-mesh Ewald (PME) software with a grid spacing of 0.75 Å. Nose-Hoover thermometry and Martyna-Tobias-Klein method were applied for maintaining the temperature and constant pressure, respectively. The formula of motion was considered using the multi run RESPA by 3.0 fs time step for bonded and non-bonded interactions within a low cutoff. An outer time step of 5.0 fs was used for non-bonded forces beyond the cutoff.
Although, accurate structures of the phosphor lipid's bilayers which are in biochemistry pertaining fluid medium are not possible for getting experimental data, fluctuations of these types of dynamic bilayers demonstrate correct structures. Quantum mechanics and Molecular dynamics simulation (QM/MM) are strong tools for tabulating and guiding the interpretation of these experimental parts. The validity of modeling may be measured in contrast existing experimental results. There are several and various techniques such as Deuterium NMR quadrupol splitting which can give certain results of physical & chemical properties. Membrane electrostatics area per lipid and membrane thickness and acyl parameters are also important to study for any further simulation. The absence of experimental data and results are reversed in molecular modeling of membrane protein (M) due to several force fields parameterization. Tight level AB-initio estimations are needed for parameterization of these types' force fields and presently allow evaluation of the heavy atoms for gaining accurate results. Moreover, there are some limitations in weak QM calculations due to London's dispersion of non-bonded interactions for such molecules. We simulated our model based on our previous works (Scheme 2) [35].
2.4. Isotropy & Anisotropy of NMR Analysis
The anisotropy data of shielding and non-shielding spaces of the hetero rings in all antibiotics, (σ11, σ22, σ33), are labeled based on IUPAC instruction. Moreover, σ33 indicates the direction of minimum shielding, with the highest frequency, while σ11 exhibited a direction of maximum shielding, with the lowest one. In addition, the orientations of the asymmetry tensors are given by
Matrine with S-protein in gas phase | Matrine with S-protein in water pH=7 | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
atom | charge | σiso | S-NICS | η | Δδ | Ω | atom | charge | σiso | S-NICS | η | Δδ | Ω |
3 C | -0.109 | 144.6 | 142.7 | 0.5679 | -20.60 | 17.52 | 3 C | -0.109 | 149.34 | 143.9 | 0.986 | -25.56 | -17.041 |
4 N | -0.217 | 146.9 | 144.9 | 0.2451 | -10.16 | 10.88 | 4 N | -0.214 | 147.43 | 146.6 | 0.500 | -11.64 | 10.345 |
5 C | 0.156 | 47.00 | 46.7 | 0.7037 | -134.3 | 105.1 | 5 C | 0.167 | 44.451 | 44.8 | 0.647 | -136.3 | 110.36 |
6 N | 0.098 | 55.50 | 55.4 | 0.9760 | -114.1 | 77.01 | 6 N | 0.096 | 56.897 | 57.5 | 0.992 | -115.3 | -76.923 |
7 C | -0.149 | 60.68 | 62.1 | 0.9963 | -114.3 | -76.2 | 7 C | -0.147 | 60.482 | 61.8 | 0.984 | -113.8 | 76.539 |
8 O | 0.191 | 47.84 | 46.8 | 0.8919 | -139.1 | -92.77 | 8 O | 0.191 | 48.078 | 49.7 | 0.884 | -138.8 | -92.595 |
1 H | -0.33 | 160.1 | 169.8 | 0.334 | -13.2 | 13.22 | 1 H | -0.340 | 159.0 | 158.7 | 0.291 | -13.4 | 13.91 |
2 C | -0.294 | 164.0 | 163.5 | 0.2341 | -4.497 | 4.858 | 2 C | -0.294 | 164.70 | 163.1 | 0.517 | -5.98 | 5.2589 |
Cytarabine with S-protein in gas phase | Cytarabine with S-protein in water pH=7 | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
atom | charge | σiso | S-NICS | η | Δδ | Ω | atom | charge | σiso | S-NICS | η | Δδ | Ω |
4 N | -0.193 | 147.65 | 145.8 | 0.511 | -12.45 | 10.989 | 4 N | -0.196 | 147.8 | 141.9 | 0.485 | -11.06 | 9.934 |
5 O | 0.1262 | 46.492 | 149.6 | 0.741 | -143.8 | 110.15 | 5 O | 0.122 | 47.31 | 46.5 | 0.757 | -143.6 | 108.95 |
6 C | -0.061 | 72.119 | 74.9 | 0.747 | -120.1 | -80.08 | 6 C | -0.060 | 70.69 | 72.4 | 0.760 | -121.3 | -80.882 |
7 N | -0.178 | 64.33 | 65.8 | 0.370 | -139.3 | -92.91 | 7 N | -0.174 | 60.01 | 61.8 | 0.544 | -139.7 | -93.18 |
8 C | 0.1905 | 57.44 | 58.9 | 0.982 | 154.3 | 103.80 | 8 C | 0.143 | 56.22 | 57.6 | 0.997 | -151.3 | 101.05 |
9 O | -0.353 | 160.51 | 164.0 | 0.495 | -15.0 | 13.43 | 9 O | -0.35 | 163.4 | 164.5 | 0.348 | -11.73 | 11.608 |
10 N | -0.33 | 161.4 | 163.3 | 0.483 | -15.8 | -10.59 | 10 N | -0.340 | 162.0 | 161.3 | 0.452 | -16.14 | -10.76 |
1 O | -0.334 | 166.51 | 167.3 | 0.624 | -10.8 | 8.936 | 1 O | -0.334 | 166.6 | 165.8 | 0.612 | -10.87 | 8.993 |
2 C | -0.287 | 165.98 | 164.7 | 0.955 | -6.175 | -4.1172 | 2 C | -0.287 | 165.8 | 164.5 | 0.875 | -6.230 | -4.1534 |
3 O | -0.090 | 144.94 | 142.9 | 0.987 | -23.8 | -15.88 | 3 O | -0.091 | 145.0 | 143.7 | 0.961 | -24.1 | -16.087 |
3. RESULTS & DISCUSSION
The amino acid sequences of target protein DNA binding ORF8, ORF3a gene [(Porcine transmissible gastroenteritis coronavirus (strain Purdue) (TGEV)], ORF10 (Beluga whale coronavirus SW1), ORFC (recombinant protein), ORF9B_SARS2 (P0DTD2), Spike glycoprotein(P0DTC2), E protein (P0DTC4), M protein (P0DTC5), ORF6 and ORF7(a) were extracted from Gen/bank in FASTA format. Vaxijen has been applied for checking the antigenicity of those related proteins. Several highly proteins as antigens were distinguished where the most of them have been founded by the S, E, M, ORF10, ORF6, ORF(7a), and ORF8.
Other physicochemical characters were predicted from protparam (Fig. 2 and Tables 4 & 5). In order for evaluating the performance of those models and in the first step, the regression model for Mpro inhibitors has been constructed using the several compounds such as E-Protein, M-Protein, S-Protein and several ORFX (X=10,8,7, 3) in ChEMBL and using Pubchem fingerprint with default neuron network parameters.
Covid-19 | Peptide | 3D Structure | |
---|---|---|---|
ORFC | KGKEKSVEET | GFMTLAGRLR | 3D Structure for Q6UDL3 |
RGMQRLSRRG | YGDNRRSRGS | ||
ENNEQDPQPG | DKIASPQRRD | ||
YTKSEASCRP | GSGKTSPCGS | ||
SGTPCSDDAG | GGRNGQENSG | ||
TRDTPCWMYK | DSKSRYRVGV | ||
TPDLIPTIFG | VSEVAASGLP | ||
RCRDKAAKRQ | PQSLLSPGVE | ||
ALLVTIAESL | ETNGKRVSGR | ||
TAGKLWSWRV | RDKAPERDYR | ||
NVTPTMFEGS | CFGKPIRAGV | ||
FNAPRAYLDD | LLGDHYFVPY | ||
LRRLPRDFTR | EETLSLRVAT | ||
EAAVFANMLW | EARHKNNFGA | ||
GVSYYPGALA | SATGTAPDFT | ||
DRGRSSLDSP | YFASTFLPGI | ||
FVILPPGELP | IDFMRLAVLL | ||
AVSAIETCVT TV | |||
ORF8 | SLQSCTQHQP | YVVDDPCPIH | |
FYSKWYIRVG | ARKSAPLIEL | ||
CVDEAGSKSP | IQYIDIGNYT | ||
VSCLPFTINC | QEPKLGSLVV |
AC | ID | Length (amino acids) | short name | full name |
---|---|---|---|---|
P0DTC9 | NCAP SARS2 | 419 | NC; Protein N; | Nucleoprotein |
P0DTC6 | NS6 SARS2 | 61 | ns6; | Non-structural protein 6 |
P0DTC7 | NS7A SARS2 | 121 | Protein 7a; | |
P0DTD8 | NS7B SARS2 | 43 | ns7b; | Protein non-structural 7b |
P0DTC8 | NS8 SARS2 | 121 | ns8; | Non-structural protein 8 |
P0DTC2 | SPIKE SARS2 | 1273 | S glycoprotein; | Spike glycoprotein |
P0DTC4 | VEMP SARS2 | 75 | E protein; sM protein | Envelope small protein |
P0DTC5 | VME1 SARS2 | 222 | M protein; | Membrane protein; E1 glycoprotein; Matrix glycoprotein membrane |
P0DTD3 | Y14 SARS2 | 73 | Uncharacterized protein 14 | |
P59632 | AP3A CVHSA | 274 | Protein 3a; | |
P59595 | NCAP CVHSA | 422 | NC; Protein N; | Nucleoprotein; |
P59633 | NS3B CVHSA | 154 | ns3b; | Non-structural protein 3b |
P59634 | NS6 CVHSA | 63 | ns6; | Non-structural protein 6 |
P59635 | NS7A CVHSA | 122 | Protein 7a | |
Q7TFA1 | NS7B CVHSA | 44 | ns7b; | Protein non-structural 7b |
Q7TFA0 | NS8A CVHSA | 39 | ns8a; | Protein non-structural 8a |
Q80H93 | NS8B CVHSA | 84 | ns8b; | Non-structural protein 8b |
P59636 | ORF9B CVHSA | 98 | Protein 9b | |
P0C6X7 | R1AB CVHSA | 7073 | pp1ab; | Replicase polyprotein 1ab; ORF1ab polyprotein; |
P0C6U8 | R1A CVHSA | 4382 | pp1a; | Replicase polyprotein 1a; ORF1a polyprotein; |
P59594 | SPIKE CVHSA | 1255 | S glycoprotein; | Spike glycoprotein; E2 |
P59637 | VEMP CVHSA | 76 | E protein; sM protein | Envelope small protein |
P59596 | VME1 CVHSA | 221 | M protein; | Membrane protein; E1 glycoprotein; Matrix glycoprotein; Membrane glycoprotein; |
The structures of all compounds were submitted to Deep Screening and predicted a suitable model via Molecular Docking of those compounds similar to several previous works [36,37]. The compounds which exhibited suitable binding energies are listed in (Figs. 2, 3) [38–40].
Therefore, for the treatment of disease, some drugs have been simulated and modeled by this work that can treat the disease and prevent it to be spread. In this regard, drug repurposing may help us for treating and preventing infections associated with Covid-19 or SARS-CoV-2 (Figs.3, 4).
In this study, we simulated several drugs from Drug bank database against the target Main protease (Mpro) for the treatment of COVID-19. Among several drugs, a few best drugs were selected, that had better binding energies as compared to the reference molecules. Based on the Binding energies scores, we can suggest that the identified drug might be considered for therapeutic development against the covid-19.
This research will help to get new drugs against COVID-19 and help humans against this pandemic disease (Fig. 4). Among the herbarium drugs we selected four molecules to be examined as anti covid-19, namely Matrine, Cytarabine, Gemcitabine and Vidarabine from which are extracted from Gillan 's plants such as Trshvash, Chuchaq, Cote D'Couto and Khlvash in Iran ([41,42].
This information with grate efficiency selected for anti-SARS-CoV-NSPs that confirm our molecular Simulation & modelling. By this work it has been shown that Cytarabine molecule (in Chuchaq), and Matrine (from Trshvash), have lower binding energies compared to the respected reference compounds. (Figs.4,5). The grids between 15-20 Å were generated over the peptide-like inhibitors of all proteins and as well as for small-molecule inhibitors. Re-docking of the Cytarabine and Matrine were accomplished to make a certain results for the docking processing. As a result the binding site for SARSCoV-2 is restricted with hydrophilic residues with mines charged (ASP, GLU) and one also positively charged (Arg). Besides those residues, ASN-955, and VAL-951 residues also interact with the ligands. Therefore the Cytarabine is a suitable inhibitor against SARS-CoV-2.
CONCLUSION
Some of the Natural products are suitable drugs against covid-19. This study exhibited an analyzing information of docking simulation that exhibited those compounds tend to form hydrogen bonds. Therefore they can be widely being explored for overcoming the current outbreak of SARS-Cov-2. Although, A few natural product molecules were introduced, but further experimental studies are needed for any further confirmation of these natural products.